Mayumi Kaneko
Papers
1
Total Citations
4
H-Index
1
About
Dr. Mayumi Kaneko is a leading urologic oncologist whose research focuses on refining surgical outcomes and prognostic models for prostate cancer. Her most impactful work centers on robot-assisted radical prostatectomy (RARP), particularly the clinical significance of positive surgical margins (PSM). In her highly cited 2024 study, Dr. Kaneko developed a novel risk classification system that leverages detailed PSM status—including location, extent, and number—to more accurately predict biochemical recurrence (BCR) after RARP. By analyzing data from over 400 patients, she demonstrated that this granular approach outperforms traditional binary PSM assessment, offering surgeons a powerful tool for postoperative risk stratification and personalized follow-up. This contribution addresses a critical gap in prostate cancer management, as BCR is a key predictor of disease progression. Dr. Kaneko’s work has already garnered attention for its potential to guide adjuvant therapy decisions, with her 2024 paper accumulating 4 citations shortly after publication. Her research exemplifies the integration of precision medicine into surgical oncology, directly impacting clinical decision-making for thousands of prostate cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1